Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net (loss) income	$ (875,377)	$ 33,030
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	77,214	87,586
Amortization of deferred financing costs and debt discount	3,698	4,014
Straight-line rent revenue and other	(46,566)	(58,566)
Stock/Unit-based compensation expense	7,633	11,829
Loss (gain) on sale of real estate	1,423	(62)
Real estate and other impairment charges, net	693,088	89,538
Straight-line rent and other write-off	1,817	2,192
Tax rate changes and other	(307)	(7,305)
Other adjustments (including fair value adjustments on securities)	223,674	(8,505)
Changes in:
Interest and rent receivables	5,369	(514)
Other assets	5,689	(2,493)
Accounts payable and accrued expenses	(18,878)	(15,696)
Deferred revenue	(4,135)	600
Net cash provided by operating activities	74,342	135,648
Investing activities
Cash paid for acquisitions and other related investments		(72,900)
Net proceeds from sale of real estate	6,596	100
Proceeds received from sale and repayment of loans receivable	114,416	221,876
Investment in loans receivable	(135,000)	(50,000)
Construction in progress and other	(29,885)	(13,292)
Proceeds from sale and return of equity investment	11,656
Capital additions and other investments, net	(87,045)	(68,606)
Net cash (used for) provided by investing activities	(119,262)	17,178
Financing activities
Revolving credit facility, net	111,186	95,919
Dividends/Distributions paid	(92,763)	(176,580)
Lease deposits and other obligations to tenants	6,226	(2,691)
Stock vesting/Unit vesting - satisfaction of tax withholdings	(283)	(5,554)
Other financing activities, payment of debt refinancing, and deferred financing costs	(2,291)	(219)
Net cash provided by (used for) financing activities	22,075	(89,125)
(Decrease) increase in cash, cash equivalents, and restricted cash for period	(22,845)	63,701
Effect of exchange rate changes	(2,889)	2,927
Cash, cash equivalents, and restricted cash at beginning of period	255,952	241,538
Cash, cash equivalents, and restricted cash at end of period	230,218	308,166
Interest paid	131,815	116,436
Supplemental schedule of non-cash financing activities:
Dividends/Distributions declared, unpaid		174,492
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	250,016	235,668
Restricted cash, included in Other assets at beginning of period	$ 5,936	$ 5,870
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 255,952	$ 241,538
Cash and cash equivalents at end of period	224,340	302,321
Restricted cash, included in Other assets at end of period	$ 5,878	$ 5,845
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 230,218	$ 308,166
MPT Operating Partnership, L.P. [Member]
Operating activities
Net (loss) income	(875,377)	33,030
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	77,214	87,586
Amortization of deferred financing costs and debt discount	3,698	4,014
Straight-line rent revenue and other	(46,566)	(58,566)
Stock/Unit-based compensation expense	7,633	11,829
Loss (gain) on sale of real estate	1,423	(62)
Real estate and other impairment charges, net	693,088	89,538
Straight-line rent and other write-off	1,817	2,192
Tax rate changes and other	(307)	(7,305)
Other adjustments (including fair value adjustments on securities)	223,674	(8,505)
Changes in:
Interest and rent receivables	5,369	(514)
Other assets	5,689	(2,493)
Accounts payable and accrued expenses	(18,878)	(15,696)
Deferred revenue	(4,135)	600
Net cash provided by operating activities	74,342	135,648
Investing activities
Cash paid for acquisitions and other related investments		(72,900)
Net proceeds from sale of real estate	6,596	100
Proceeds received from sale and repayment of loans receivable	114,416	221,876
Investment in loans receivable	(135,000)	(50,000)
Construction in progress and other	(29,885)	(13,292)
Proceeds from sale and return of equity investment	11,656
Capital additions and other investments, net	(87,045)	(68,606)
Net cash (used for) provided by investing activities	(119,262)	17,178
Financing activities
Revolving credit facility, net	111,186	95,919
Dividends/Distributions paid	(92,763)	(176,580)
Lease deposits and other obligations to tenants	6,226	(2,691)
Stock vesting/Unit vesting - satisfaction of tax withholdings	(283)	(5,554)
Other financing activities, payment of debt refinancing, and deferred financing costs	(2,291)	(219)
Net cash provided by (used for) financing activities	22,075	(89,125)
(Decrease) increase in cash, cash equivalents, and restricted cash for period	(22,845)	63,701
Effect of exchange rate changes	(2,889)	2,927
Cash, cash equivalents, and restricted cash at beginning of period	255,952	241,538
Cash, cash equivalents, and restricted cash at end of period	230,218	308,166
Interest paid	131,815	116,436
Supplemental schedule of non-cash financing activities:
Dividends/Distributions declared, unpaid		174,492
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	250,016	235,668
Restricted cash, included in Other assets at beginning of period	$ 5,936	$ 5,870
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 255,952	$ 241,538
Cash and cash equivalents at end of period	224,340	302,321
Restricted cash, included in Other assets at end of period	$ 5,878	$ 5,845
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 230,218	$ 308,166